Literature DB >> 24250975

Comparison of the Length of Hospital Stay between the Patients with Atrial Fibrillation Treated with Amiodarone and Patients with Normal Sinus Rhythm after Coronary Artery Bypass Graft.

Samad Shams Vahdati1, Jahanbakhsh Samadikhah, Seied Hadi Hakim, Rasoul Azarfarin, Mahsa Ansarin.   

Abstract

INTRODUCTION: Postoperative atrial fibrillation occurs in 20 % to 40 % of patients undergoing coronary artery bypass grafting ( CABG ) and contributes to increasing length of stay and hospital cost . The purpose of our study was to compare the length of hospital stay between patients of postoperative atrial fibrillation treated with amiodarone (experimental) and those with normal sinus rhythm ( NSR ) (Control ) after CABG.
METHODS: From October of 2008 to October 2010, our experimental group including 26 patients was treated with amiodarone in Tabriz Madani Heart Center. The background variables, length of atrial fibrillation, and length of hospital stay were recorded. The experimental group was compared with a control group of 50 patients. The two groups were the same in terms of age, gender, ejection fraction, vascular diseases and risk factors.
RESULTS: The hospital stay duration was 8.0 ±1.6 and 7.4 ±1.4 days (p = 0.08) for experimental, and control groups respectively. Atrial fibrillation occurred mainly (60%) on the second postoperative day.
CONCLUSION: 25 patients out of 26 patients (96 %) returned to NSR after starting the amiodarone protocol and the length of hospital stay in the experimental group was not significantly different from that of the control group. Thus, treating with Amiodarone in postoperative atrial fibrillation can reduce hospital stay duration compared to that of normal sinus patients.

Entities:  

Keywords:  Amiodarone; Atrial Fibrillation; Heart Surgery; Length of hospital stay

Year:  2012        PMID: 24250975      PMCID: PMC3825346          DOI: 10.5681/jcvtr.2012.004

Source DB:  PubMed          Journal:  J Cardiovasc Thorac Res        ISSN: 2008-5117


  20 in total

1.  Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Authors:  M B Rosenbaum; P A Chiale; D Ryba; M V Elizari
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

2.  Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery.

Authors:  J D Redle; S Khurana; R Marzan; P A McCullough; J R Stewart; D C Westveer; W W O'Neill; J S Bassett; N A Tepe; H I Frumin
Journal:  Am Heart J       Date:  1999-07       Impact factor: 4.749

3.  Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial.

Authors:  T Guarnieri; S Nolan; S O Gottlieb; A Dudek; D R Lowry
Journal:  J Am Coll Cardiol       Date:  1999-08       Impact factor: 24.094

4.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery.

Authors:  E G Daoud; S A Strickberger; K C Man; R Goyal; G M Deeb; S F Bolling; F D Pagani; C Bitar; M D Meissner; F Morady
Journal:  N Engl J Med       Date:  1997-12-18       Impact factor: 91.245

5.  Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation.

Authors:  K Peuhkurinen; M Niemelä; A Ylitalo; M Linnaluoto; M Lilja; J Juvonen
Journal:  Am J Cardiol       Date:  2000-02-15       Impact factor: 2.778

Review 6.  Proarrhythmia in patients treated for atrial fibrillation or flutter.

Authors:  R H Falk
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

7.  Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.

Authors:  H J Wellens; P Brugada; H Abdollah
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

8.  Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.

Authors:  S H Hohnloser; T Meinertz; T Dammbacher; K Steiert; E Jähnchen; M Zehender; G Fraedrich; H Just
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

9.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

10.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

View more
  1 in total

Review 1.  Amiodaron in atrial fibrillation: post coronary artery bypass graft.

Authors:  Paria Habibollahi; Shahrzad Hashemi Jam; Samad Shams Vahdati; Hamidreza Morteza Baghi; Hassan Amiri
Journal:  World J Emerg Med       Date:  2016
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.